# Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib

> **NCT00815971** · — · UNKNOWN · sponsor: **Aarhus University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00815971
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2008-12-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815971, "Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00815971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*